SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-004578
Filing Date
2022-01-07
Accepted
2022-01-07 17:15:53
Documents
14
Period of Report
2021-12-31
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d267523d8k.htm   iXBRL 8-K 27672
2 EX-99.1 d267523dex991.htm EX-99.1 6364
6 GRAPHIC g267523g0108023401447.jpg GRAPHIC 2189
  Complete submission text file 0001193125-22-004578.txt   159106

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA gh-20211231.xsd EX-101.SCH 2890
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE gh-20211231_lab.xml EX-101.LAB 17372
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gh-20211231_pre.xml EX-101.PRE 10953
8 EXTRACTED XBRL INSTANCE DOCUMENT d267523d8k_htm.xml XML 3220
Mailing Address 505 PENOBSCOT DR. REDWOOD CITY CA 94063
Business Address 505 PENOBSCOT DR. REDWOOD CITY CA 94063 855-698-8887
Guardant Health, Inc. (Filer) CIK: 0001576280 (see all company filings)

IRS No.: 454139254 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38683 | Film No.: 22518939
SIC: 8071 Services-Medical Laboratories